
Supportive Care
Latest News
Advertisement
Video Series
Latest Videos
CME Content
Advertisement
More News













Refaat Hegazi, MD, PhD, MPH, discusses nutrition-related toxicities in oncology.

The advent of immunotherapy options to treat patients with cancer has brought with it a new wave of immuno-related toxicities. One institution, Massachusetts General Hospital, has taken steps to establish an immunotherapy toxicity service care team, inspired by a 65-year-old patient with metastatic melanoma that had spread to his lungs and brain.

Cardiac resynchronization therapy improved heart function in patients who developed chemotherapy-induced cardiomyopathy.

The FDA has accepted a biologics license application to review eflapegrastim for the management of chemotherapy-induced neutropenia.









Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
4
Five Under 5: Top Oncology Videos for the Week of 1/25
5























































